SCHEMBL28624545

SCHEMBL28624545

CCn1c(CC2CCCC2)nnc1C(=O)O

nearest known ligand 0.44

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
RORC P51449 5/20 0.44
SMN1; SMN2 Q16637 3/20 0.37
ADORA2A P29274 2/20 0.36
ADORA2B P29275 2/20 0.36
ADORA1 P30542 1/20 0.36
CYP3A4 P08684 1/20 0.35
VCP P55072 2/20 0.35
ALDH1A1 P00352 3/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
KDM4E B2RXH2 2/20 0.33
TSHR P16473 1/20 0.33
THRB P10828 1/20 0.33
HPGD P15428 1/20 0.33
POLB P06746 1/20 0.33
CYP2C19 P33261 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28920788 0.68 HTT (0.60) SMN1; SMN2CYP3A4ALDH1A1MEN1KMT2A
SCHEMBL18413732 0.64 ALDH1A1 (0.36) SMN1; SMN2ALDH1A1MEN1KMT2AKDM4E
SCHEMBL28920802 0.63 HTT (0.42) SMN1; SMN2CYP3A4ALDH1A1MEN1KMT2A
SCHEMBL761369 0.63 CDK4 (0.41) RORCADORA2AADORA2BVCPALDH1A1
SCHEMBL17471423 0.61 TSHR (0.38) SMN1; SMN2ADORA2BADORA1ALDH1A1MEN1
SCHEMBL17243992 0.60 MEN1 (0.38) CYP3A4ALDH1A1MEN1KMT2AKDM4E
SCHEMBL5558085 0.60 ALDH1A1 (0.37) RORCSMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL15964620 0.59 KDM5B (0.40) ADORA2AADORA2BADORA1
SCHEMBL15964621 0.58 KDM5B (0.41) ADORA2AADORA2BADORA1
SCHEMBL8467019 0.58 ALDH1A1 (0.37) RORCSMN1; SMN2VCPALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113166116-B Amido bridged heterocyclic compound, and composition and application thereof 北京赛特明强医药科技有限公司 2022-12-27 CN disclosed
CN-113166116-A Amido bridged heterocyclic compound, and composition and application thereof 北京赛特明强医药科技有限公司 2021-07-23 CN disclosed